Thanks to Team Malabar Cancer Center Dr Manu, Dr Praveen and Dr Nizam for the wonderfully conducted UROCON 2022. Great hospitality and great sessions on uro oncology and a chance to catch up with the TMH gang.

Phase III Randomized Trial for Use of Docetaxel in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation. Vanita Noronha, MBBS MD DM Amol Patel Nandini Menon Ezra Cohen Journal of Clinical Oncology P.D.Hinduja Hospital Khar Tata Memorial Hospital Robert Haddad ascopubs.org/doi/abs/10.120…

Our new issue is out! Looking forward to your comments and criticism. Sincere thanks to all authors, reviewers, editors and publishers for your contribution. Read more: bit.ly/3Kf29px Vanita Noronha, MBBS MD DM Dr Arun Chandran Avinash Pandey MD DM Aju Mathew @rakesh_jalali Dr Ullas Batra

"Cancer creeps in, Shadow cast, hearts heavy with pain. Hope blooms like a rose." This was a Cancer Haiku generated by ChatGPT on my request. Just Incredible ! ! Cannot discern the real and artificial.. Dr (Prof). Vijay Patil Dr Amol Akhade Sujith Sudeep Nair Aju Mathew

🚨Major Publication: A Phase 3 randomised study showing Oral Metronomic combination failed to improve OS or PFS post-CR after radica chemo radiation thus observation remains standard of care. Dr (Prof). Vijay Patil Vanita Noronha, MBBS MD DM The Lancet The Lancet Reg Health-Southeast Asia sciencedirect.com/science/articl…

Fewer than 1 in 100 older Indian patients with cancer receive routine immunization with influenza and pneumococcal vaccines. Dr Prabhash and team study the uptake of vaccines in older patients. Read here: bit.ly/42KkL7f #CRST #geriatric #oncology #vaccines #Cancer

The molecular tumor board presents a case-based review of the tumor suppressing gene SMAD4. Read here: bit.ly/42xQHvo #CRST #SMAD4 #tumorboard #Cancer #CancerResearch #oncology #oncologists

Types of speakers at Medical Conferences - 1. Entertainer - invited by organisers specially for what it says on the tin. They tell many jokes, poems, WhatsApp forwards and present memes in the talk. Audience laughs. These speakers are like a fart after big meal. No substance but

New video on chemotherapy and radiation youtu.be/VzegJ-bFrhc

Question: What is worse than an Ayush practitioner peddling pseudoscience to defraud people who do not know better? Answer: An actual medical practitioner who scams people with scientific jargons and pushes absolutely useless therapies to make an extra buck. And the best

Long-term outcomes of neo-adjuvant chemotherapy on borderline resectab... sciencedirect.com/science/articl…. 10 year results with Bordeline oral cavity cancer Ezra Cohen Vanita Noronha, MBBS MD DM Nandini Menon

I don't know who needs to know this more ( oncologist or patients or both ) But this is one of the best piece about cancer and diet misinformation in The Lancet Oncology. Say NO to ketogenic diets , alkaline diets as treatment options. Say NO to Quackery .

What to do post cdk4/6 inhibitors? How to fit in all new agents ? Money slide. By Dr Carlos H Barrios. SABCS #SABCS23

Number of tourists in Maldeves from 2011 to 2023 #BoycottMaldives #VisitLakshadweep

Finally #Borderlineresectable has arrived. RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as NACT in borderline resectable oral cancer - EJC ejcancer.com/article/S0959-… Prof. Anil D'Cruz Christina Henson, MD The ASCO Post Vanita Noronha, MBBS MD DM TMH Medical Oncology Alumni Ezra Cohen Head and Neck Cancer International Group

Proud to share results of ph3 RCT in 495 pts w/ borderline resectable oral ca. OS with TPF > TP. Half pts who underwent surgery were alive at 5 yr vs 5% for who didnt ejcancer.com/article/S0959-… OncoAlert Dr (Prof). Vijay Patil Dr. Pankaj Chaturvedi Sumanta K. Pal, MD, FASCO Neeraj Agarwal, MD, FASCO #hncsm #headandneckcancer

Congratulations ⁦Nandini Menon⁩. Results in of low dose Bev with CCNU in GBM ⁦ASCO⁩ ⁦Dr Amol Akhade⁩ ⁦Amol Patel⁩ ⁦Dr Ameya Puranik⁩

I had a terrible experience today with an Ola auto. I booked a ride from Brookfield to Kormangala with a stop at Mahadevpura. The app quoted ₹292, but when I reached my destination, the driver demanded ₹455. He insisted the app was wrong and threatened to hold me until I